Two Sigma Securities’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,339
Closed -$20.7K 3511
2022
Q4
$20.7K Buy
+12,339
New +$69.1K ﹤0.01% 2271
2022
Q1
Sell
-1,594
Closed -$34K 2701
2021
Q4
$34K Buy
+1,594
New +$53.9K ﹤0.01% 1340
2019
Q1
Sell
-69
Closed -$10K 2674
2018
Q4
$10K Buy
+69
New +$17.3K ﹤0.01% 2021
2017
Q4
Sell
-50
Closed -$10K 2127
2017
Q3
$10K Buy
+50
New +$11.1K ﹤0.01% 868

Other funds holding ONCS

Two Sigma Securities's ONCS Position: Q1 2023 in Review

Two Sigma Securities sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 12,339 shares — an estimated $20.7K sold.

Two Sigma Securities first reported a position in ONCS in Q3 2017 and held it in 4 quarters. The position peaked at $34K in Q4 2021. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

  • Two Sigma Securities reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 12,339 OncoSec Medical Incorporated shares in Q1 2023, an estimated $20.7K.
  • Two Sigma Securities first reported a position in OncoSec Medical Incorporated in Q3 2017 and held it in 4 quarters.
  • Two Sigma Securities's OncoSec Medical Incorporated position peaked at $34K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.